PDB Short entry for 1DIG HEADER OXIDOREDUCTASE,HYDROLASE 29-NOV-99 1DIG TITLE HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE TITLE 2 COMPLEXED WITH NADP AND INHIBITOR LY374571 COMPND MOL_ID: 1; COMPND 2 MOLECULE: METHYLENETETRAHYDROFOLATE DEHYDROGENASE / CYCLOHYDROLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DC301; COMPND 5 EC: 1.5.1.5, 3.5.4.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TETRAHYDROFOLATE, DEHYDROGENASE, CYCLOHYDROLASE, NADP, INHIBITOR, KEYWDS 2 ROSSMANN FOLD, OXIDOREDUCTASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.SCHMIDT,H.WU,R.E.MACKENZIE,V.J.CHEN,J.R.BEWLY,J.E.RAY,J.E.TOTH, AUTHOR 2 M.CYGLER REVDAT 4 07-FEB-24 1DIG 1 REMARK REVDAT 3 31-JAN-18 1DIG 1 REMARK REVDAT 2 24-FEB-09 1DIG 1 VERSN REVDAT 1 05-JUL-00 1DIG 0 JRNL AUTH A.SCHMIDT,H.WU,R.E.MACKENZIE,V.J.CHEN,J.R.BEWLY,J.E.RAY, JRNL AUTH 2 J.E.TOTH,M.CYGLER JRNL TITL STRUCTURES OF THREE INHIBITOR COMPLEXES PROVIDE INSIGHT INTO JRNL TITL 2 THE REACTION MECHANISM OF THE HUMAN JRNL TITL 3 METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE. JRNL REF BIOCHEMISTRY V. 39 6325 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10828945 JRNL DOI 10.1021/BI992734Y REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.ALLAIRE,Y.LI,R.E.MACKENZIE,M.CYGLER REMARK 1 TITL THE 3-D STRUCTURE OF A FOLATE-DEPENDENT REMARK 1 TITL 2 DEHYDROGENASE/CYCLOHYDROLASE BIFUNCTIONAL ENZYME AT 1.5 A REMARK 1 TITL 3 RESOLUTION REMARK 1 REF STRUCTURE V. 6 173 1998 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(98)00019-7 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 29650 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2900 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4396 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 131 REMARK 3 SOLVENT ATOMS : 218 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT CORRECTION APPLIED REMARK 4 REMARK 4 1DIG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-DEC-99. REMARK 100 THE DEPOSITION ID IS D_1000010112. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29810 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.04400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.14700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, GLYCEROL, SODIUM CITRATE, REMARK 280 AMMONIUM ACETATE, PH 5.2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 20K, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.94450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.78950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.20950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.78950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.94450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.20950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DC301 FORMS DIMERS, THE TWO MONOMERS (CHAINS A AND B) BEING REMARK 300 RELATED BY A NONCRYSTALLOGRAPHIC TWOFOLD AXIS IN THE CRYSTAL REMARK 300 STRUCTURE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 VAL A 241 REMARK 465 PRO A 242 REMARK 465 ASP A 243 REMARK 465 ASP A 244 REMARK 465 LYS A 245 REMARK 465 LYS A 246 REMARK 465 PRO A 247 REMARK 465 ASN A 248 REMARK 465 GLY A 249 REMARK 465 ARG A 250 REMARK 465 LYS A 297 REMARK 465 PHE A 298 REMARK 465 LYS A 299 REMARK 465 PRO A 300 REMARK 465 GLY A 301 REMARK 465 LYS A 302 REMARK 465 TRP A 303 REMARK 465 MET A 304 REMARK 465 ILE A 305 REMARK 465 GLN A 306 REMARK 465 MET B 1001 REMARK 465 LYS B 1297 REMARK 465 PHE B 1298 REMARK 465 LYS B 1299 REMARK 465 PRO B 1300 REMARK 465 GLY B 1301 REMARK 465 LYS B 1302 REMARK 465 TRP B 1303 REMARK 465 MET B 1304 REMARK 465 ILE B 1305 REMARK 465 GLN B 1306 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 83 CG CD CE NZ REMARK 480 GLU A 296 CG CD OE1 OE2 REMARK 480 GLU B 1296 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 45 47.46 -148.67 REMARK 500 VAL A 177 -66.36 -125.36 REMARK 500 ASN B1045 44.23 -148.06 REMARK 500 ARG B1173 34.43 -143.16 REMARK 500 VAL B1177 -73.07 -127.25 REMARK 500 ALA B1215 80.15 -150.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L37 A 3001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A4I RELATED DB: PDB REMARK 900 STRUCTURE OF THE NATIVE HUMAN METHYLENETETRAHYDROFOLATE REMARK 900 DEHYDROGENASE / CYCLOHYDROLASE (DC301) COMPLEXED WITH THE COFACTOR REMARK 900 NADP REMARK 900 RELATED ID: 1DIA RELATED DB: PDB REMARK 900 RELATED ID: 1DIB RELATED DB: PDB DBREF 1DIG A 1 306 UNP P11586 C1TC_HUMAN 1 306 DBREF 1DIG B 1001 1306 UNP P11586 C1TC_HUMAN 1 306 SEQRES 1 A 306 MET ALA PRO ALA GLU ILE LEU ASN GLY LYS GLU ILE SER SEQRES 2 A 306 ALA GLN ILE ARG ALA ARG LEU LYS ASN GLN VAL THR GLN SEQRES 3 A 306 LEU LYS GLU GLN VAL PRO GLY PHE THR PRO ARG LEU ALA SEQRES 4 A 306 ILE LEU GLN VAL GLY ASN ARG ASP ASP SER ASN LEU TYR SEQRES 5 A 306 ILE ASN VAL LYS LEU LYS ALA ALA GLU GLU ILE GLY ILE SEQRES 6 A 306 LYS ALA THR HIS ILE LYS LEU PRO ARG THR THR THR GLU SEQRES 7 A 306 SER GLU VAL MET LYS TYR ILE THR SER LEU ASN GLU ASP SEQRES 8 A 306 SER THR VAL HIS GLY PHE LEU VAL GLN LEU PRO LEU ASP SEQRES 9 A 306 SER GLU ASN SER ILE ASN THR GLU GLU VAL ILE ASN ALA SEQRES 10 A 306 ILE ALA PRO GLU LYS ASP VAL ASP GLY LEU THR SER ILE SEQRES 11 A 306 ASN ALA GLY ARG LEU ALA ARG GLY ASP LEU ASN ASP CYS SEQRES 12 A 306 PHE ILE PRO CYS THR PRO LYS GLY CYS LEU GLU LEU ILE SEQRES 13 A 306 LYS GLU THR GLY VAL PRO ILE ALA GLY ARG HIS ALA VAL SEQRES 14 A 306 VAL VAL GLY ARG SER LYS ILE VAL GLY ALA PRO MET HIS SEQRES 15 A 306 ASP LEU LEU LEU TRP ASN ASN ALA THR VAL THR THR CYS SEQRES 16 A 306 HIS SER LYS THR ALA HIS LEU ASP GLU GLU VAL ASN LYS SEQRES 17 A 306 GLY ASP ILE LEU VAL VAL ALA THR GLY GLN PRO GLU MET SEQRES 18 A 306 VAL LYS GLY GLU TRP ILE LYS PRO GLY ALA ILE VAL ILE SEQRES 19 A 306 ASP CYS GLY ILE ASN TYR VAL PRO ASP ASP LYS LYS PRO SEQRES 20 A 306 ASN GLY ARG LYS VAL VAL GLY ASP VAL ALA TYR ASP GLU SEQRES 21 A 306 ALA LYS GLU ARG ALA SER PHE ILE THR PRO VAL PRO GLY SEQRES 22 A 306 GLY VAL GLY PRO MET THR VAL ALA MET LEU MET GLN SER SEQRES 23 A 306 THR VAL GLU SER ALA LYS ARG PHE LEU GLU LYS PHE LYS SEQRES 24 A 306 PRO GLY LYS TRP MET ILE GLN SEQRES 1 B 306 MET ALA PRO ALA GLU ILE LEU ASN GLY LYS GLU ILE SER SEQRES 2 B 306 ALA GLN ILE ARG ALA ARG LEU LYS ASN GLN VAL THR GLN SEQRES 3 B 306 LEU LYS GLU GLN VAL PRO GLY PHE THR PRO ARG LEU ALA SEQRES 4 B 306 ILE LEU GLN VAL GLY ASN ARG ASP ASP SER ASN LEU TYR SEQRES 5 B 306 ILE ASN VAL LYS LEU LYS ALA ALA GLU GLU ILE GLY ILE SEQRES 6 B 306 LYS ALA THR HIS ILE LYS LEU PRO ARG THR THR THR GLU SEQRES 7 B 306 SER GLU VAL MET LYS TYR ILE THR SER LEU ASN GLU ASP SEQRES 8 B 306 SER THR VAL HIS GLY PHE LEU VAL GLN LEU PRO LEU ASP SEQRES 9 B 306 SER GLU ASN SER ILE ASN THR GLU GLU VAL ILE ASN ALA SEQRES 10 B 306 ILE ALA PRO GLU LYS ASP VAL ASP GLY LEU THR SER ILE SEQRES 11 B 306 ASN ALA GLY ARG LEU ALA ARG GLY ASP LEU ASN ASP CYS SEQRES 12 B 306 PHE ILE PRO CYS THR PRO LYS GLY CYS LEU GLU LEU ILE SEQRES 13 B 306 LYS GLU THR GLY VAL PRO ILE ALA GLY ARG HIS ALA VAL SEQRES 14 B 306 VAL VAL GLY ARG SER LYS ILE VAL GLY ALA PRO MET HIS SEQRES 15 B 306 ASP LEU LEU LEU TRP ASN ASN ALA THR VAL THR THR CYS SEQRES 16 B 306 HIS SER LYS THR ALA HIS LEU ASP GLU GLU VAL ASN LYS SEQRES 17 B 306 GLY ASP ILE LEU VAL VAL ALA THR GLY GLN PRO GLU MET SEQRES 18 B 306 VAL LYS GLY GLU TRP ILE LYS PRO GLY ALA ILE VAL ILE SEQRES 19 B 306 ASP CYS GLY ILE ASN TYR VAL PRO ASP ASP LYS LYS PRO SEQRES 20 B 306 ASN GLY ARG LYS VAL VAL GLY ASP VAL ALA TYR ASP GLU SEQRES 21 B 306 ALA LYS GLU ARG ALA SER PHE ILE THR PRO VAL PRO GLY SEQRES 22 B 306 GLY VAL GLY PRO MET THR VAL ALA MET LEU MET GLN SER SEQRES 23 B 306 THR VAL GLU SER ALA LYS ARG PHE LEU GLU LYS PHE LYS SEQRES 24 B 306 PRO GLY LYS TRP MET ILE GLN HET NAP A2001 48 HET L37 A3001 31 HET ACT B4000 4 HET NAP B2002 48 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM L37 [[N'-(2,5-DIAMINO-6-HYDROXY-PYRIMIDIN-4-YL)-UREAYL]- HETNAM 2 L37 PHEN-4-YL]-CARBONYL-GLUTAMIC ACID HETNAM ACT ACETATE ION HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN L37 LY374571 FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 L37 C17 H19 N7 O7 FORMUL 5 ACT C2 H3 O2 1- FORMUL 7 HOH *218(H2 O) HELIX 1 1 ASN A 8 VAL A 31 1 24 HELIX 2 2 ARG A 46 GLY A 64 1 19 HELIX 3 3 THR A 77 ASP A 91 1 15 HELIX 4 4 ASN A 110 ASN A 116 1 7 HELIX 5 5 ALA A 117 ILE A 118 5 2 HELIX 6 6 ALA A 119 LYS A 122 5 4 HELIX 7 7 THR A 128 ARG A 137 1 10 HELIX 8 8 PRO A 146 GLU A 158 1 13 HELIX 9 9 VAL A 177 TRP A 187 1 11 HELIX 10 10 HIS A 201 ASN A 207 1 7 HELIX 11 11 ALA A 257 LYS A 262 1 6 HELIX 12 12 GLY A 274 GLU A 296 1 23 HELIX 13 13 ASN B 1008 VAL B 1031 1 24 HELIX 14 14 ARG B 1046 GLY B 1064 1 19 HELIX 15 15 THR B 1077 ASP B 1091 1 15 HELIX 16 16 ASN B 1110 ASN B 1116 1 7 HELIX 17 17 ALA B 1117 ILE B 1118 5 2 HELIX 18 18 ALA B 1119 LYS B 1122 5 4 HELIX 19 19 THR B 1128 ARG B 1137 1 10 HELIX 20 20 PRO B 1146 GLU B 1158 1 13 HELIX 21 21 VAL B 1177 TRP B 1187 1 11 HELIX 22 22 HIS B 1201 ASN B 1207 1 7 HELIX 23 23 ALA B 1257 LYS B 1262 1 6 HELIX 24 24 VAL B 1275 PRO B 1277 5 3 HELIX 25 25 MET B 1278 GLU B 1296 1 19 SHEET 1 A12 GLU A 5 ILE A 6 0 SHEET 2 A12 PHE A 267 ILE A 268 1 N ILE A 268 O GLU A 5 SHEET 3 A12 ILE A 232 ASP A 235 1 N VAL A 233 O PHE A 267 SHEET 4 A12 ILE A 211 VAL A 214 1 O LEU A 212 N ILE A 234 SHEET 5 A12 HIS A 167 VAL A 171 1 O HIS A 167 N ILE A 211 SHEET 6 A12 THR A 191 CYS A 195 1 O THR A 191 N ALA A 168 SHEET 7 A12 THR B1191 CYS B1195 -1 O VAL B1192 N THR A 194 SHEET 8 A12 HIS B1167 VAL B1171 1 N ALA B1168 O THR B1191 SHEET 9 A12 ILE B1211 VAL B1214 1 O ILE B1211 N VAL B1169 SHEET 10 A12 ILE B1232 ASP B1235 1 O ILE B1232 N LEU B1212 SHEET 11 A12 PHE B1267 ILE B1268 1 O PHE B1267 N VAL B1233 SHEET 12 A12 GLU B1005 ILE B1006 1 O GLU B1005 N ILE B1268 SHEET 1 B 3 LYS A 66 LEU A 72 0 SHEET 2 B 3 ARG A 37 VAL A 43 1 N LEU A 38 O LYS A 66 SHEET 3 B 3 GLY A 96 VAL A 99 1 O GLY A 96 N ALA A 39 SHEET 1 C 3 LYS B1066 LEU B1072 0 SHEET 2 C 3 ARG B1037 VAL B1043 1 N LEU B1038 O LYS B1066 SHEET 3 C 3 GLY B1096 VAL B1099 1 N GLY B1096 O ARG B1037 SHEET 1 D 2 ASN B1239 PRO B1242 0 SHEET 2 D 2 ARG B1250 VAL B1253 -1 N LYS B1251 O VAL B1241 CISPEP 1 LEU A 101 PRO A 102 0 0.39 CISPEP 2 VAL A 271 PRO A 272 0 0.07 CISPEP 3 LEU B 1101 PRO B 1102 0 0.02 CISPEP 4 VAL B 1271 PRO B 1272 0 -0.62 SITE 1 AC1 5 PRO A 162 GLN B1023 GLU B1289 LYS B1292 SITE 2 AC1 5 HOH B4208 SITE 1 AC2 20 THR A 148 ARG A 173 SER A 174 HIS A 196 SITE 2 AC2 20 SER A 197 LEU A 202 ALA A 215 THR A 216 SITE 3 AC2 20 GLY A 217 GLN A 218 MET A 221 CYS A 236 SITE 4 AC2 20 ILE A 238 GLY A 276 THR A 279 L37 A3001 SITE 5 AC2 20 HOH A4011 HOH A4111 HOH A4112 HOH A4163 SITE 1 AC3 22 THR B1148 GLY B1172 ARG B1173 SER B1174 SITE 2 AC3 22 HIS B1196 SER B1197 ALA B1215 THR B1216 SITE 3 AC3 22 GLY B1217 GLN B1218 MET B1221 CYS B1236 SITE 4 AC3 22 ILE B1238 GLY B1276 THR B1279 HOH B4025 SITE 5 AC3 22 HOH B4026 HOH B4087 HOH B4088 HOH B4107 SITE 6 AC3 22 HOH B4198 HOH B4201 SITE 1 AC4 9 LYS A 56 LEU A 101 ILE A 238 GLY A 273 SITE 2 AC4 9 GLY A 274 GLY A 276 PRO A 277 NAP A2001 SITE 3 AC4 9 HOH A4012 CRYST1 67.889 136.419 61.579 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014730 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007330 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016239 0.00000